Measuring Cannabinoid Receptors
Who Can Enroll?
This study is open to U.S. Veterans aged 18-65 who have experienced a traumatic event.
Participants must be medically healthy, not pregnant or breastfeeding, and not using any elicit substances.
Individuals with substance abuse, psychotic disorders, severe claustrophobia, or embedded metal may not participate.
What Will I Do?
Participants will be asked to take part in the following procedures:
Medical evaluation (blood draw, urine test, EKG, and history and physical)
Self report questionnaires
A 1 hour MRI Scan
A 6 hour PET Scan Appointment
Receive up to $650.00 compensation.
1) Click the link below to complete our pre screening survey
2) If you screen in, you will be directed to our contact form. We will then contact you with a 5-15 minute over the phone, phone screen consisting of basic demographic, mental health and physical health questions to help determine your eligibility.
3) Should you remain interested and eligible, we will bring you in for an in-person screening appointment.
Yale HIC#: 1005006735
About The Study:
This exploratory neurobiological study analyzes the presence of the Cannabinoid Type 1 (CB1) receptor in the brain of those who have been exposed to trauma.
The CB1 receptor may play a role in learning and memory processes. Importantly, CB1 receptors have been found in brain regions that control fear and stress responses
Our study is made up of three appointments: a screening appointment to determine your eligibility, an MRI scan, and a PET scan. You can receive up to $650.00 compensation.
Our goal is to better understand the neurobiological underpinnings of PTSD and those exposed to trauma. This research may be applied to help improve future treatments for PTSD.